Compositions and methods for cancer therapy
US10052304B2 · kind B2 · utility
4Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2016 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Nov 11, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2005/1098
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods to treat a hyperproliferative disorder with ascorbate or a pharmaceutically acceptable salt thereof, at least one chelating agent that enhances ascorbate redox cycling (EDTA) to form H2O2, and one or more anti-cancer therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.